Once-daily tiotropium Respimat® add-on to ICS + LABA improves symptom control and reduces exacerbations in patients with symptomatic asthma

David Price, Michael Engel, Petra Moroni-Zentgraf, H. Schmidt, Pierluigi Paggiaro, Mark Vandewalker, Huib A M Kerstjens, Alan Kaplan

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2014
StatusUdgivet - 2014

Bibliografisk note

Thorax 2014;69:Suppl 2 A49-A50 doi:10.1136/thoraxjnl-2014-206260.97

Citationsformater